Silverfin false false 30/06/2026 01/07/2025 30/06/2026 Alfred David Allen 11/06/2014 Richard Oliver Allen 11/06/2014 08 October 2026 The principal activity of the company in the year under review was the contract manufacture, distribution and sale of Vitamin D3 supplements to the UK and export markets. 09082655 2026-06-30 09082655 bus:Director1 2026-06-30 09082655 bus:Director2 2026-06-30 09082655 2025-06-30 09082655 core:CurrentFinancialInstruments 2026-06-30 09082655 core:CurrentFinancialInstruments 2025-06-30 09082655 core:ShareCapital 2026-06-30 09082655 core:ShareCapital 2025-06-30 09082655 core:RetainedEarningsAccumulatedLosses 2026-06-30 09082655 core:RetainedEarningsAccumulatedLosses 2025-06-30 09082655 core:Goodwill 2025-06-30 09082655 core:OtherResidualIntangibleAssets 2025-06-30 09082655 core:Goodwill 2026-06-30 09082655 core:OtherResidualIntangibleAssets 2026-06-30 09082655 core:PlantMachinery 2025-06-30 09082655 core:ComputerEquipment 2025-06-30 09082655 core:PlantMachinery 2026-06-30 09082655 core:ComputerEquipment 2026-06-30 09082655 2025-07-01 2026-06-30 09082655 bus:FilletedAccounts 2025-07-01 2026-06-30 09082655 bus:SmallEntities 2025-07-01 2026-06-30 09082655 bus:AuditExemptWithAccountantsReport 2025-07-01 2026-06-30 09082655 bus:PrivateLimitedCompanyLtd 2025-07-01 2026-06-30 09082655 bus:Director1 2025-07-01 2026-06-30 09082655 bus:Director2 2025-07-01 2026-06-30 09082655 core:Goodwill core:TopRangeValue 2025-07-01 2026-06-30 09082655 core:OtherResidualIntangibleAssets core:TopRangeValue 2025-07-01 2026-06-30 09082655 core:PlantMachinery core:TopRangeValue 2025-07-01 2026-06-30 09082655 core:ComputerEquipment core:TopRangeValue 2025-07-01 2026-06-30 09082655 2024-07-01 2025-06-30 09082655 core:Goodwill 2025-07-01 2026-06-30 09082655 core:OtherResidualIntangibleAssets 2025-07-01 2026-06-30 09082655 core:PlantMachinery 2025-07-01 2026-06-30 09082655 core:ComputerEquipment 2025-07-01 2026-06-30 iso4217:GBP xbrli:pure

Company No: 09082655 (England and Wales)

SUNVIT-D3 LIMITED

Unaudited Financial Statements
For the financial year ended 30 June 2026
Pages for filing with the registrar

SUNVIT-D3 LIMITED

Unaudited Financial Statements

For the financial year ended 30 June 2026

Contents

SUNVIT-D3 LIMITED

COMPANY INFORMATION

For the financial year ended 30 June 2026
SUNVIT-D3 LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 30 June 2026
DIRECTORS Alfred David Allen
Richard Oliver Allen
REGISTERED OFFICE 2 Leman Street
London
E1W 9US
United Kingdom
COMPANY NUMBER 09082655 (England and Wales)
ACCOUNTANT Gravita Essex Limited
Kings House
101-135 Kings Road
Brentwood
Essex
CM14 4DR
United Kingdom
SUNVIT-D3 LIMITED

BALANCE SHEET

As at 30 June 2026
SUNVIT-D3 LIMITED

BALANCE SHEET (continued)

As at 30 June 2026
Note 2026 2025
£ £
Fixed assets
Intangible assets 3 9,591 13,132
Tangible assets 4 80 123
9,671 13,255
Current assets
Stocks 464,047 470,953
Debtors 5 1,144,245 755,656
Cash at bank and in hand 6 2,134,076 1,897,061
3,742,368 3,123,670
Creditors: amounts falling due within one year 7 ( 628,999) ( 464,402)
Net current assets 3,113,369 2,659,268
Total assets less current liabilities 3,123,040 2,672,523
Provision for liabilities ( 301) ( 301)
Net assets 3,122,739 2,672,222
Capital and reserves
Called-up share capital 100 100
Profit and loss account 3,122,639 2,672,122
Total shareholder's funds 3,122,739 2,672,222

For the financial year ending 30 June 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Sunvit-D3 Limited (registered number: 09082655) were approved and authorised for issue by the Board of Directors on 08 October 2026. They were signed on its behalf by:

Richard Oliver Allen
Director
SUNVIT-D3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2026
SUNVIT-D3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Sunvit-D3 Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2 Leman Street, London, E1W 9US, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 5 years straight line
Other intangible assets 3 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 5 years straight line
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 5 5

3. Intangible assets

Goodwill Other intangible assets Total
£ £ £
Cost
At 01 July 2025 14,196 13,133 27,329
At 30 June 2026 14,196 13,133 27,329
Accumulated amortisation
At 01 July 2025 2,839 11,358 14,197
Charge for the financial year 2,839 702 3,541
At 30 June 2026 5,678 12,060 17,738
Net book value
At 30 June 2026 8,518 1,073 9,591
At 30 June 2025 11,357 1,775 13,132

4. Tangible assets

Plant and machinery Computer equipment Total
£ £ £
Cost
At 01 July 2025 40,262 4,203 44,465
At 30 June 2026 40,262 4,203 44,465
Accumulated depreciation
At 01 July 2025 40,139 4,203 44,342
Charge for the financial year 43 0 43
At 30 June 2026 40,182 4,203 44,385
Net book value
At 30 June 2026 80 0 80
At 30 June 2025 123 0 123

5. Debtors

2026 2025
£ £
Trade debtors 1,115,056 740,384
Other debtors 29,189 15,272
1,144,245 755,656

6. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 2,134,076 1,897,061

7. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 148,102 110,088
Amounts owed to Group undertakings 92,797 72,311
Taxation and social security 195,854 167,672
Other creditors 192,246 114,331
628,999 464,402

8. Ultimate controlling party

Parent Company:

ADAllen Pharma Limited